Skip to main content

Inspection visit

Health inspection

Bridgecrest Rehabilitation SuitesCMS #6763621 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

676362 02/10/2025 Bridgecrest Rehabilitation Suites 14100 Karissa Court Houston, TX 77049
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review the facility failed to provide pharmaceutical services (including procedures that assure the accurate administering of all drugs and biologicals) to meet the needs of each resident for 1 of 2 residents (Resident #1) reviewed for pharmacy services. MA K attempted to administer Resident #23's Hydrochlorothiazide (used to treat high blood pressure and fluid retention) to Resident #1 instead of Hydralazine (used to lower blood pressure and improve blood flow) as ordered by the MD. This failure could place residents at risk of medication errors resulting in exacerbation or deterioration in health conditions. Findings include: Record review of Resident #1's face sheet revealed a [AGE] year-old female who readmitted to the facility on [DATE]. Her diagnoses included hyperkalemia (high potassium), hypertension (high blood pressure), and pulmonary heart disease. Record review of Resident #1's quarterly MDS assessment dated [DATE] revealed a BIMS score of 12 out of 15 which indicated moderate cognitive impairment. She required assistance from staff with ADL care. Record review of Resident #1's care plan edited 2/7/25 revealed she was at risk for signs and symptoms of hyper/hypotension related to diagnosis of hypertension. Nifedipine (medication used to treat high blood pressure and angina), carvedilol (medication used to treat heart failure, hypertension, and heart attack) as ordered. The approach was to administer medications as ordered. Record review of Resident #1's Physician Orders for February 2025 revealed an order for Hydralazine 25 mg give 75 mg every 6 hours, order date 11/9/24. Record review of Resident #1's MAR dated 1/26/25 - 2/8/25 revealed Hydralazine 25 mg give 3 tablets for hypertension was scheduled 4 times a day at 12:00 a.m., 6:00 a.m., 12:00 p.m. and 6:00 p.m. In an interview on 2/8/25 at 2:29 p.m., Resident #1 said she received Hydralazine every 6 hours but did not receive the medication on some shifts. In an observation and interview on 2/8/25 at 5:02 p.m., MA K began medication administration for Page 1 of 2 676362 676362 02/10/2025 Bridgecrest Rehabilitation Suites 14100 Karissa Court Houston, TX 77049
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Resident #1. She retrieved Resident #23's Hydrochlorothiazide 25 mg from the cart and placed 3 tablets in the medication cup. MA K locked the medication cart and entered Resident #1's room. This Surveyor intervened and asked MA K to return to the medication cart to verify the medication. Observation revealed the medication in the cup (Resident #23's Hydrochlorothiazide) did not match the medication in Resident #1's blister pack (Hydralazine). MA K said she could not read the imprint on the tablet and said she may have grabbed the wrong blister pack. She said the blister pack was in the wrong spot and the medication she prepared for Resident #1 belonged to Resident #23. She destroyed Resident #23's Hydrochlorothiazide and prepared Hydralazine 25 mg 3 tablets and administered it to Resident #1. In an interview on 2/8/25 at 5:19 p.m., MA K said she checked the MAR and blister pack to verify the correct amount, dosage, and time. She said she reviewed the medication name and the dosage and thought it matched. She said she noticed it was a different medication when the Surveyor said something. She said she must have placed Resident #23's medication in Resident #1's spot on the medication cart. She said Hydralazine was for Resident #1's blood pressure. In an interview on 2/8/25 at 5:24 p.m., the DON said nursing staff should follow the rights of medication administration which included verifying the right patient and to compare the MAR to what was on hand. She said (Hydralazine) was a blood pressure medication and (Hydrochlorothiazide) was a diuretic (used to increase urine production and help lower blood pressure and fluid retention). She said the risk included medication error, and it could be detrimental. Record review of the facility's Medication Management policy dated 4/7/24 read in part, .The staff and practitioners shall strive to minimize potential for medication error by: A. Following the :8 Rights for administering medication: 1. The right patient/resident, 2. The right drug . 676362 Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

FAQ · About this visit

Common questions about this visit

What happened during the February 10, 2025 survey of Bridgecrest Rehabilitation Suites?

This was a inspection survey of Bridgecrest Rehabilitation Suites on February 10, 2025. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at Bridgecrest Rehabilitation Suites on February 10, 2025?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.